Evidence map›Paper›PMID 30378732›Full record

ArticleAddiction biology2020

Neuronal nicotinic acetylcholine receptors mediate ∆

Giulia Donvito, Pretal P Muldoon, Kia J Jackson, Urslan Ahmad, Nur T Zaveri, J Michael McIntosh, Xiangning Chen, Aron H Lichtman, M Imad Damaj

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Addiction biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Crosstalk between the MCellular signalling · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Giulia DonvitoDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.ORCID 0000-0003-2394-7590
Pretal P MuldoonDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Kia J JacksonDepartment of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
Urslan AhmadDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Nur T ZaveriAstraea Therapeutics, Mountain View, CA, USA.
J Michael McIntoshDepartments of Biology and Psychiatry, University of Utah, Salt Lake City, UT, USA.
Xiangning ChenNevada Institute of Personalized Medicine, University of Nevada, Las Vegas, NV, USA.
Aron H LichtmanDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
M Imad DamajDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Virginia Commonwealth University · USAstraea Therapeutics (United States) · USUniversity of Nevada, Las Vegas · USUniversity of Utah · US

Funding

Subject CollectionU10AA008401 · NIAAA · SUNY DOWNSTATE MEDICAL CENTER · PI JAY Arnold TISCHFIELD · 1989 to 2026
$162.7M
Venoms, Biological Resources, Molecular BiologyP01GM048677 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 1993 to 2018
$32.2M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
The Collaborative Genetic Study of Nicotine DependenceP01CA089392 · NCI · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2001 to 2012
$17.3M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
Novel nAChR-Targeted PeptidesR01GM103801 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2012 to 2019
$2.4M
FAMILY STUDY OF COCAINE DEPENDENCER01DA013423 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA JEAN · 2000 to 2004
$2.2M
(PQ9) Mitigation of chemotherapy induced peripheral neuropathyR01CA206028 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD, GEWIRTZ, DAVID A. · 2016 to 2020
$1.7M
Genes and molecular pathways in nicotine dependence and withdrawalR01DA032246 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD, MILES, MICHAEL F · 2013 to 2017
$1.7M
Study of Addiction: Genetics and EnvironmentU01HG004422 · NHGRI · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2007 to 2010
$1.2M
NCI NIH HHS P01 CA089392NCI NIH HHS R01 CA206028NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004422NHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01 HG004446NIAAA NIH HHS U10 AA008401NIDA NIH HHS R01 DA013423NIDA NIH HHS R01 DA032246NIGMS NIH HHS P01 GM048677NIGMS NIH HHS R01 GM103801
6 · The paper itself

Abstract

Cessation from prolonged use of ∆

Indexed as

AnimalsCannabinoid Receptor AntagonistsDisease Models, AnimalDronabinolHumansMarijuana AbuseMiceMice, Inbred C57BLMice, KnockoutReceptors, NicotinicRimonabantSubstance Withdrawal SyndromeCannabinoid Receptor AntagonistsDronabinolReceptors, NicotinicRimonabanthuman geneticsmicenicotinic acetylcholine receptorssomatic signsTHCwithdrawal

Identifiers

PMID30378732
PMCPMC6509006
OpenAlexW2899071334

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.